| Identification | Back Directory | [Name]
2-Thiophenecarboxylic acid, 5-[(5-fluoro-2-pyridinyl)oxy]-4-[(4-methylbenzoyl)amino]- | [CAS]
2989271-65-8 | [Synonyms]
2-Thiophenecarboxylic acid, 5-[(5-fluoro-2-pyridinyl)oxy]-4-[(4-methylbenzoyl)amino]- | [Molecular Formula]
C18H13FN2O4S | [MOL File]
2989271-65-8.mol | [Molecular Weight]
372.37 |
| Chemical Properties | Back Directory | [Boiling point ]
471.2±45.0 °C(predicted) | [density ]
1.462±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | [pka]
3.78±0.10(predicted) |
| Hazard Information | Back Directory | [Uses]
P2Y14R antagonist 2 (compound 39) is a potent, selective and orally active P2Y14R antagonist with an IC50 value of 0.40 nM. P2Y14R antagonist 2 shows anti-inflammatory activity. P2Y14R antagonist 2 has the potential for the research of colitis[1]. | [in vivo]
P2Y14R antagonist 2 (50, 100 μM for 100μL per mice; rectally administered, daily for 7 days) shows anti-inflammatory activity in mice with colitis[1].
Pharmacokinetic Parameters[1].
| Parameters | dose (mg/kg) | Cmax (ng/mL) | T1/2 (min) | Tmax (min) | AUCall (min*ng/mL) | CL (mL/min/kg) | F (%) | | iv | 1.0 | - | 21 ± 8.4 | - | 27924 ± 5520 | 133.8 ± 33 | - | | po | 5.0 | 518.25 ± 196.26 | 177.6 ± 24.6 | 15 | 90744 ± 21613 | 232.2 ± 46.2 | 65.0 |
| Animal Model: | 6-8 weeks, 20-22 g, male C57BL/6 mice (colitis) [1] | | Dosage: | 50, 100 μM for 100μL per mice | | Administration: | Rectally administered, daily for 7 days | | Result: | Alleviated DSS-induced body weight loss, loose stools, rectal bleeding, colon shortening, and elevated spleen weighted index. |
| [IC 50]
P2Y14 Receptor: 0.40 nM (IC50) | [References]
[1] Wang YH, et al. Discovery of a Series of 4-Amide-thiophene-2-carboxyl Derivatives as Highly Potent P2Y14 Receptor Antagonists for Inflammatory Bowel Disease Treatment. J Med Chem. 2024 Jul 3. DOI:10.1021/acs.jmedchem.4c00699 |
|
|